| Eosinophil's role remains uncertain as anti–interleukin-5 only partially depletes numbers in asthmatic airway PT Flood-Page, AN Menzies-Gow, AB Kay, DS Robinson American journal of respiratory and critical care medicine 167 (2), 199-204, 2003 | 967 | 2003 |
| Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics P Flood-Page, A Menzies-Gow, S Phipps, S Ying, A Wangoo, MS Ludwig, ... The Journal of clinical investigation 112 (7), 1029-1036, 2003 | 949 | 2003 |
| Tezepelumab in adults and adolescents with severe, uncontrolled asthma A Menzies-Gow, J Corren, A Bourdin, G Chupp, E Israel, ME Wechsler, ... New England Journal of Medicine 384 (19), 1800-1809, 2021 | 627 | 2021 |
| The biology of eosinophils and their role in asthma CN McBrien, A Menzies-Gow Frontiers in medicine 4, 93, 2017 | 361 | 2017 |
| Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult … J Sweeney, CC Patterson, A Menzies-Gow, RM Niven, AH Mansur, ... Thorax 71 (4), 339-346, 2016 | 340 | 2016 |
| Anti–IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics A Menzies-Gow, P Flood-Page, R Sehmi, J Burman, Q Hamid, ... Journal of Allergy and Clinical Immunology 111 (4), 714-719, 2003 | 320 | 2003 |
| Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies JM FitzGerald, ER Bleecker, A Menzies-Gow, JG Zangrilli, I Hirsch, ... The Lancet Respiratory Medicine 6 (1), 51-64, 2018 | 313 | 2018 |
| U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics D Lefaudeux, B De Meulder, MJ Loza, N Peffer, A Rowe, F Baribaud, ... Journal of Allergy and Clinical Immunology 139 (6), 1797-1807, 2017 | 298 | 2017 |
| Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early-and late-phase allergic reactions … A Menzies-Gow, S Ying, I Sabroe, VL Stubbs, D Soler, TJ Williams, ... The Journal of Immunology 169 (5), 2712-2718, 2002 | 289 | 2002 |
| Co‐morbidities in severe asthma: C linical impact and management C Porsbjerg, A Menzies‐Gow Respirology 22 (4), 651-661, 2017 | 254 | 2017 |
| Systematic literature review of systemic corticosteroid use for asthma management ER Bleecker, AN Menzies-Gow, DB Price, A Bourdin, S Sweet, AL Martin, ... American journal of respiratory and critical care medicine 201 (3), 276-293, 2020 | 249 | 2020 |
| Characterization of severe asthma worldwide: data from the International Severe Asthma Registry E Wang, ME Wechsler, TN Tran, LG Heaney, RC Jones, AN Menzies-Gow, ... Chest 157 (4), 790-804, 2020 | 246 | 2020 |
| The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry S O'Neill, J Sweeney, CC Patterson, A Menzies-Gow, R Niven, ... Thorax 70 (4), 376-378, 2015 | 219 | 2015 |
| Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry LG Heaney, CE Brightling, A Menzies-Gow, M Stevenson, RM Niven, ... Thorax 65 (9), 787-794, 2010 | 218 | 2010 |
| Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma ER Bleecker, ME Wechsler, JM FitzGerald, A Menzies-Gow, Y Wu, ... European Respiratory Journal 52 (4), 2018 | 217 | 2018 |
| Integrated care pathways for airway diseases (AIRWAYS-ICPs) J Bousquet, A Addis, I Adcock, I Agache, A Agusti, A Alonso, ... European Respiratory Journal 44 (2), 304-323, 2014 | 215 | 2014 |
| Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind … S Diver, L Khalfaoui, C Emson, SE Wenzel, A Menzies-Gow, ME Wechsler, ... The Lancet Respiratory Medicine 9 (11), 1299-1312, 2021 | 203 | 2021 |
| An expert consensus framework for asthma remission as a treatment goal A Menzies-Gow, M Bafadhel, WW Busse, TB Casale, JWH Kocks, ... Journal of Allergy and Clinical Immunology 145 (3), 757-765, 2020 | 201 | 2020 |
| Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI D Gibeon, K Batuwita, M Osmond, LG Heaney, CE Brightling, R Niven, ... Chest 143 (2), 406-414, 2013 | 173 | 2013 |
| Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma NC Thomson, R Chaudhuri, LG Heaney, C Bucknall, RM Niven, ... Journal of Allergy and Clinical Immunology 131 (4), 1008-1016, 2013 | 172 | 2013 |
